1961
DOI: 10.1378/chest.39.2.158
|View full text |Cite
|
Sign up to set email alerts
|

The Concentration of I131 in the Bronchial Tree after Oral Administration of Tagged CaI2 and KI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1963
1963
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…Intriguingly, iodide has been used to thin mucus secretions in the respiratory tract as an expectorant drug for asthma or other pulmonary diseases [20]. It was also found that orally administered radio-iodide reaches bronchial lumen [21]. This transport of iodide across the bronchial mucosa may be conducted by NIS.…”
Section: Discussionmentioning
confidence: 99%
“…Intriguingly, iodide has been used to thin mucus secretions in the respiratory tract as an expectorant drug for asthma or other pulmonary diseases [20]. It was also found that orally administered radio-iodide reaches bronchial lumen [21]. This transport of iodide across the bronchial mucosa may be conducted by NIS.…”
Section: Discussionmentioning
confidence: 99%
“…SVDs are invariably associated with PAPVR ( 1 ). The classic surgical approach is placement of a patch-baffle that closes the defect and redirects anomalous pulmonary veins into the left atrium, with a risk for venous obstruction ( 2 ). Superior insertion of pulmonary veins extends the length of the baffle with increased risk for obstruction.…”
Section: Casementioning
confidence: 99%
“…In fact, this can be easily observed if some PVPI solution is added drop wise directly into excess CaCl 2 solution, where the characteristic orange color of PVPI slowly turns colorless. CaI 2 is a standard medicinal compound which is especially effective for bronchopulmonary diseases having also a partial antiseptic effect (Lopez-Belio, Henderson, Mansueto, & Holinger, 1961). Therefore, formation of CaI 2 is not considered as a drawback but as an added functionality opening up new application possibilities for these beads such as orally administered antiseptic and expectorant (cough, asthma, bronchitis and cystic fibrosis releaving agent).…”
Section: Measurement Of Pvpi Release From Naalg Films and Caalg Beadsmentioning
confidence: 99%